Abstract
Epigenetic silencing of cancer-related genes plays an important role in oral/oropharyngeal squamous cell carcinoma (OSCC). We evaluated promoter hypermethylation of 4 cancer-related genes in OSCCs of a Brazilian cohort and determined its relationship with exposure to alcohol, tobacco, HPV infection and clinicopathological parameters. CDKN2A (cyclin-dependent kinase inhibitor 2A or p16), SFN (stratifin or 14-3-3 σ), EDNRB (endothelin receptor B) and RUNX3 (runt-related transcript factor-3) had their methylation patterns evaluated by MSP analysis in OSCC tumors (n = 45). HPV detection was carried out by PCR/RFLP. Aberrant methylation was detected in 44/45 (97.8 %) OSCC; 24.4 % at CDKN2A, 77.8 % at EDNRB, 17.8 % at RUNX3 and 97.8 % at SFN gene. There was no significant association between methylation patterns and clinical parameters. HPV (subtype 16) was detected in 3 out of 45 patients (6 %). Our findings indicate that HPV infection is uncommon and methylation is frequent in Brazilian OSCCs, however, EDNRB and SFN gene methylation are not suitable OSCC biomarkers due to indistinct methylation in tumoral and normal samples. In contrast, CDKN2A and RUNX3 genes could be considered differentially methylated genes and potential tumor markers in OSCCs.
Similar content being viewed by others
References
Scully C, Bedi R (2000) Ethnicity and oral cancer. Lancet Oncol 1:37–42
Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA: Cancer J Clin 2:74–108
Silverman S Jr. (2001) Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J Am Dent Assoc 132:7–11
Scully C, Bagan J (2009) Oral squamous cell carcinoma overview. Oral Oncol 45:301–308
Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:622–635
Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8:3187–3192
Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol Biomarkers Prev 14:467–475
Fakhry C, Gillison ML (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24:2606–2611
Stebbing J, Bower M, Syed N, Smith P, Yu V, Crook T (2006) Epigenetics: an emerging technology in the diagnosis and treatment of cancer. Pharmacogenomics 7:747–757
Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054
Ha PK, Califano JA (2006) Promoter methylation and inactivation of tumoursuppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7:77–82
Supić G, Kozomara R, Branković-Magić M, Jović N, Magić Z (2009) Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 45:1051–1057
Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225–3229
Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT (2004) Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 23:1000–1004
Tran TN, Liu Y, Takagi M, Yamaguchi A, Fujii H (2005) Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. J Oral Pathol Med 34:150–156
Marsit CJ, McClean MD, Furniss CS, Kelsey KT (2006) Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 119:1761–1766
Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT (2007) Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 28:1745–1751
Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT (2002) Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21:4231–4236
Dikshit RP, Gillio-Tos A, Brennan P et al (2007) Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110:1745–1751
Marsit CJ, Posner MR, McClean MD, Kelsey KT (2008) Hypermethylation of Ecadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer 113:1566–1571
Zheng DL, Zhang L, Cheng N et al (2009) Epigenetic modification induced by hepatitis B virus × protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50:377–387
Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS (2002) The Epstein Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99:10084–10089
Shamay M, Krithivas A, Zhang J, Hayward SD (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi’s sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci USA 103:14554–14559
Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA et al (2007) Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120:2165–2169
Wu MF, Cheng YW, Lai JC et al (2005) Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 113:440–445
Au Yeung CL, Tsang WP, Tsang TY, Co NN, Yau PL, Kwok TT (2010) HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep 24:1599–1604
Leonard SM, Wei W, Collins SI et al (2012) Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women. Carcinogenesis. doi:10.1093/carcin/bgs157
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826
Ferguson AT, Evron E, Umbricht CB et al (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049–6054
Jerónimo C, Henrique R, Campos PF et al (2003) Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 56: 52–5
Kim TY, Lee HJ, Hwang KS et al (2004) Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84:479–484
Bender CM, Pao MM, Jones PA (1998) Inhibition of DNA methylation by 5-aza-20-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58:95–101
Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10:903–910
Kim WJ, Kim EJ, Jeong P et al (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65:9347–9354
Negraes PD, Favaro FP, Camargo JL et al (2008) DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection. BMC Cancer 8:238
Husnjak K, Grce M, Magdić L, Pavelić K (2000) Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 88(2):125–134
Shaw RJ, Liloglou T, Rogers SN et al (2006) Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94:561–568
Sinha P, Bahadur S, Thakar A et al (2009) Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck 31:1423–1430
Taioli E, Ragin C, Wang XH et al (2009) Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer 6:354
Kaur J, Demokan S, Tripathi SC et al (2010) Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer 127:2367–2373
Yakushiji T, Noma H, Shibahara T et al (2001) Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 42:159–168
Cordeiro-Silva MF, Oliveira ZF, de Podestá JR, Gouvea SA, Von Zeidler SV, Louro ID (2011) Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep 38:5435–5441
Ogi K, Toyota M, Ohe-Toyota M et al (2002) Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 8:3164–3171
Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S (2008) Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev 17:414–420
Demokan S, Chang X, Chuang A et al. (2010) KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 127: 2351-9
Toyooka S, Maruyama R, Toyooka KO et al (2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 103:153–160
Ku JL, Kang SB, Shin YK et al (2004) Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23: 6736–42
Ito K, Liu Q, Salto-Tellez M et al (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65:7743–7750
Kim WJ, Kim EJ, Jeong P et al (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65:9347–9354
Mor T, Nomoto S, Koshikawa K et al (2005) Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 25:380–388
Yanada M, Yaoi T, Shimada J et al (2005) Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol Rep 14:817–822
Gao F, Huang C, Lin M et al (2009) Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol 135:739–747
Gasco M, Bell AK, Heath V et al (2002) Epigenetic inactivation of 14-3-3 d in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res 62:2072–2076
Bhawal UK, Tsukinoki K, Sasahira T et al (2007) Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Oncol Rep 18: 817–24
Bhatia K, Siraj AK, Hussain A, Bu R, Gutierrez MI (2003) The tumor suppressor gene 14-3-3σ is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev 12:165–169
Lombaerts M, Middeldorp JW, van der Weide E et al (2004) Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Biochem Biophys Res Commun 319:697–704
Dietrich D, Lesche R, Tetzner R et al (2009) Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J Histochem Cytochem 57:477–489
Gannot G, Gannot I, Vered H, Buchner A, Keisari Y (2002) Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br J Cancer 86:1444–1448
Brock MV, Gou M, Akiyama Y et al (2003) Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 9:2912–2919
de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papilomavirus detection by PCR. J Gen Virol 76:1057–1062
Smith EM, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP (2010) Tobacco and alcohol use increases the risk of both HPV-associated and HPV independent head and neck cancers. Cancer Causes Control 21(9):1369–1378
Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012:571862
Gillison ML, D’Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407–420
Machado J, Reis PP, Zhang T et al (2010) Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 12:2–6
Liang XH, Lewis J, Foote R, Smith D, Kademani D (2008) Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 66(9):1875–1880
Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M (2012) Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 1:104–120
Acay R, Rezende N, Fontes A, Aburad A, Nunes F, Sousa S (2008) Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification. Oral Microbiol Immunol 23:271–274
de Spíndula-Filho JV, da Cruz AD, Oton-Leite AF et al (2011) Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV). Tumour Biol 32:409–416
Soares RC, Oliveira MC, de Souza LB, Costa Ade L, Pinto LP (2008) Detection of HPV DNA and immunohistochemical expression of cell cycle proteins in oral carcinoma in a population of Brazilian patients. J Appl Oral Sci 16:340–344
Rivero ER, Nunes FD (2006) HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR. Br Oral Res 20(1):21–4
Furrer VE, Benitez MB, Furnes M, Lanfranchi HE, Modesti NM (2006) Biopsy vs superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med 35:338–344
Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME et al (2008) High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 39:189–197
Chang F, Syrjänen S, Kellokoski J, Syrjänen K (1991) Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med 20:305–317
Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9
Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8:3187–3192
Smith EM, Ritchie JM, Summersgill KF et al (2004) (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108:766–772
van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130(8):1806–1812
Fonseca-Silva T, Farias LC, Cardoso CM et al (2012) Analysis of p16(CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia. Pathobiology 79(2):94–100
Acknowledgments
We would like to thank PRPPG–UFES for donating methylSEQr™ Bisulfite Conversion Kits. MFCS was sponsored by a CAPES scholarship. We thank the Head and Neck Departments of the Araújo Jorge Hospital, GO and Santa Rita de Cássia Hospital, ES, Brazil for helping with sample collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Freitas Cordeiro-Silva, M., Stur, E., Agostini, L.P. et al. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep 39, 10111–10119 (2012). https://doi.org/10.1007/s11033-012-1885-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1885-4